|
1
|
Arnold M, Moore SP, Hassler S,
Ellison-Loschmann L, Forman D and Bray F: The burden of stomach
cancer in indigenous populations: A systematic review and global
assessment. Gut. 63:64–71. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fock KM and Ang TL: Epidemiology of
Helicobacter pylori infection and gastric cancer in Asia. J
Gastroenterol Hepatol. 25:479–486. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao X, Li X and Yuan H: microRNAs in
gastric cancer invasion and metastasis. Front Biosci (Landmark Ed).
18:803–810. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ventura A and Jacks T: MicroRNAs and
cancer: Short RNAs go a long way. Cell. 136:586–591. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wagner S, Ngezahayo A, Escobar Murua H and
Nolte I: Role of miRNA let-7 and its major targets in prostate
cancer. Biomed Res Int. 2014:3763262014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Yang M, Yao Y, Eades G, Zhang Y and Zhou
Q: miR-28 regulates Nrf2 expression through a Keap1-independent
mechanism. Breast Cancer Res Treat. 129:983–991. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Almeida MI, Nicoloso MS, Zeng L, Ivan C,
Spizzo R, Gafà R, Xiao L, Zhang X, Vannini I, Fanini F, et al:
Strand-specific miR-28-5p and miR-28-3p have distinct effects in
colorectal cancer cells. Gastroenterology. 142(886–896):
e92012.
|
|
10
|
Schneider C, Setty M, Holmes AB, Maute RL,
Leslie CS, Mussolin L, Rosolen A, Dalla-Favera R and Basso K:
MicroRNA 28 controls cell proliferation and is down-regulated in
B-cell lymphomas. Proc Natl Acad Sci USA. 111:8185–8190. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Malzkorn B, Wolter M, Liesenberg F,
Grzendowski M, Stühler K, Meyer HE and Reifenberger G:
Identification and functional characterization of microRNAs
involved in the malignant progression of gliomas. Brain Pathol.
20:539–550. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Edge SB, Byrd DR, Compton CC, Fritz AG,
Greene FL and Trotti A: AJCC Cancer Staging Manual. 7th edition.
Springer-Verlag; New York: pp. 347–377. 2010
|
|
13
|
Cheng Z, Liu F, Wang G, Li Y, Zhang H and
Li F: miR-133 is a key negative regulator of CDC42-PAK pathway in
gastric cancer. Cell Signal. 26:2667–2673. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Li Z, Gu X, Fang Y, Xiang J and Chen Z:
microRNA expression profiles in human colorectal cancers with brain
metastases. Oncol Lett. 3:346–350. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li LL, Qu LL, Fu HJ, Zheng XF, Tang CH, Li
XY, Chen J, Wang WX, Yang SX, Wang L, et al: Circulating microRNAs
as novel biomarkers of ALK-positive nonsmall cell lung cancer and
predictors of response to crizotinib therapy. Oncotarget.
8:45399–45414. 2017.PubMed/NCBI
|
|
17
|
Zhou SL, Hu ZQ, Zhou ZJ, Dai Z, Wang Z,
Cao Y, Fan J, Huang XW and Zhou J: miR-28-5p-IL-34-macrophage
feedback loop modulates hepatocellular carcinoma metastasis.
Hepatology. 63:1560–1575. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Lim EL, Trinh DL, Scott DW, Chu A,
Krzywinski M, Zhao Y, Robertson AG, Mungall AJ, Schein J, Boyle M,
et al: Comprehensive miRNA sequence analysis reveals survival
differences in diffuse large B-cell lymphoma patients. Genome Biol.
16:182015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Rizzo M, Berti G, Russo F, Evangelista M,
Pellegrini M and Rainaldi G: The miRNA pull out assay as a method
to validate the miR-28-5p targets identified in other tumor
contexts in prostate cancer. Int J Genomics. 2017:52148062017.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang G, Zhang Q, Song Y, Wang X, Guo Q,
Zhang J, Li J, Han Y, Miao Z and Li F: PAK1 regulates
RUFY3-mediated gastric cancer cell migration and invasion. Cell
Death Dis. 6:e16822015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Guo Q, Su N, Zhang J, Li X, Miao Z, Wang
G, Cheng M, Xu H, Cao L and Li F: PAK4 kinase-mediated SCG10
phosphorylation involved in gastric cancer metastasis. Oncogene.
33:3277–3287. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fukui H, Zhang X, Sun C, Hara K, Kikuchi
S, Yamasaki T, Kondo T, Tomita T, Oshima T, Watari J, et al: IL-22
produced by cancer-associated fibroblasts promotes gastric cancer
cell invasion via STAT3 and ERK signaling. Br J Cancer.
111:763–771. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sasaki T and Kuniyasu H: Significance of
AKT in gastric cancer (Review). Int J Oncol. 45:2187–2192. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Danaei G, Vander Hoorn S, Lopez AD, Murray
CJ and Ezzati M: Comparative Risk Assessment collaborating group
(Cancers): Causes of cancer in the world: Comparative risk
assessment of nine behavioural and environmental risk factors.
Lancet. 366:1784–1793. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Shen L, Shan YS, Hu HM, Price TJ, Sirohi
B, Yeh KH, Yang YH, Sano T, Yang HK, Zhang X, et al: Management of
gastric cancer in Asia: Resource-stratified guidelines. Lancet
Oncol. 14:e535–e547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Takahashi T, Saikawa Y and Kitagawa Y:
Gastric cancer: Current status of diagnosis and treatment. Cancers
(Basel). 5:48–63. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hochwald SN, Kim S, Klimstra DS, Brennan
MF and Karpeh MS: Analysis of 154 actual five-year survivors of
gastric cancer. J Gastrointest Surg. 4:520–525. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhong J, Chen Y and Wang LJ: Emerging
molecular basis of hematogenous metastasis in gastric cancer. World
J Gastroenterol. 22:2434–2440. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Xu Y, Jin J, Liu Y, Huang Z, Deng Y, You
T, Zhou T, Si J and Zhuo W: Snail-regulated miR-375 inhibits
migration and invasion of gastric cancer cells by targeting JAK2.
PLoS One. 9:e995162014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Liu Z, Zhu J, Cao H, Ren H and Fang X:
miR-10b promotes cell invasion through RhoC-AKT signaling pathway
by targeting HOXD10 in gastric cancer. Int J Oncol. 40:1553–1560.
2012.PubMed/NCBI
|
|
31
|
Shi X and Teng F: Down-regulated miR-28-5p
in human hepatocellular carcinoma correlated with tumor
proliferation and migration by targeting insulin-like growth
factor-1 (IGF-1). Mol Cell Biochem. 408:283–293. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wang C, Hu J, Lu M, Gu H, Zhou X, Chen X,
Zen K, Zhang CY, Zhang T, Ge J, et al: A panel of five serum miRNAs
as a potential diagnostic tool for early-stage renal cell
carcinoma. Sci Rep. 5:76102015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fu H, Hu Z, Wen J, Wang K and Liu Y:
TGF-beta promotes invasion and metastasis of gastric cancer cells
by increasing fascin1 expression via ERK and JNK signal pathways.
Acta Biochim Biophys Sin (Shanghai). 41:648–656. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li LH, Luo Q, Zheng MH, Pan C, Wu GY, Lu
YZ, Feng B, Chen XH and Liu BY: P21-activated protein kinase 1 is
overexpressed in gastric cancer and induces cancer metastasis.
Oncol Rep. 27:1435–1442. 2012.PubMed/NCBI
|
|
35
|
Bellacosa A, Kumar CC, Di Cristofano A and
Testa JR: Activation of AKT kinases in cancer: Implications for
therapeutic targeting. Adv Cancer Res. 94:29–86. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yuan D, Xia H, Zhang Y, Chen L, Leng W,
Chen T, Chen Q, Tang Q, Mo X, Liu M and Bi F: P-Akt/miR-200
signaling regulates epithelial-mesenchymal transition, migration
and invasion in circulating gastric tumor cells. Int J Oncol.
45:2430–2438. 2014. View Article : Google Scholar : PubMed/NCBI
|
